EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN RECOMBINANT IMMUNOFLUORESCENT ASSAY

Test, Antigen, Nuclear, Epstein-barr Virus

MRL DIAGNOSTICS

The following data is part of a premarket notification filed by Mrl Diagnostics with the FDA for Epstein-barr Virus Nuclear Antigen Recombinant Immunofluorescent Assay.

Pre-market Notification Details

Device IDK946353
510k NumberK946353
Device Name:EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN RECOMBINANT IMMUNOFLUORESCENT ASSAY
ClassificationTest, Antigen, Nuclear, Epstein-barr Virus
Applicant MRL DIAGNOSTICS 10703 PROGRESS WAY Cypress,  CA  90630 -4737
ContactBill Hyatt
CorrespondentBill Hyatt
MRL DIAGNOSTICS 10703 PROGRESS WAY Cypress,  CA  90630 -4737
Product CodeLLM  
CFR Regulation Number866.3235 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1994-12-30
Decision Date1995-07-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.